Sunrest Lifescience IPO Review & Recommendations

Sunrest Lifescience IPO Peer Comparison

Sunrest Lifescience Limited peer comparison with similar listed entities. (Standalone) (As on March 31, 2023)

Notes:

(i) Considering the nature, range of products/services, turnover, and size of the business of the Company, the peers are not strictly comparable. However, the above Companies have been included for broad comparison.

(ii) The figures for Sunrest Lifescience Limited are based on the Restated Financial Information for the year ended March 31, 2023.

(iv) Financial information for listed peers mentioned above is sourced from the annual reports as available of the respective peers for the year ended March 31, 2023, submitted to Stock Exchanges.

(v) NAV is computed as the closing net worth divided by the closing outstanding number of equity shares. Net worth has been computed as the aggregate of share capital and other equity (excluding Revaluation Reserves, if any) and as attributable to the owners of the Company.

(vi) The P/E Ratio has been computed based on the closing market price of equity shares on the stock exchange divided by the Basic EPS as of March 31, 2023.

(vii) RoNW is computed as net profit after tax, as attributable to the owners of the Company divided by closing net worth. Net worth has been computed as the aggregate of share capital and other equity (excluding Revaluation Reserves, if any) and as attributable to the owners of the Company.

(viii) Sunrest Lifescience Limited is a Fixed Price Issue.

(ix) The Issue Price has been determined by the company in consultation with the LM based on an assessment of market demand from investors for the equity shares and is justified based on the above qualitative and quantitative parameters.